Dahan et al., 2011 - Google Patents

TCR‐like antibodies distinguish conformational and functional differences in two‐versus four‐domain auto reactive MHC class II–peptide complexes

Dahan et al., 2011

View PDF
Document ID
7229756991915292069
Author
Dahan R
Tabul M
Chou Y
Meza‐Romero R
Andrew S
Ferro A
Burrows G
Offner H
Vandenbark A
Reiter Y
Publication year
Publication venue
European journal of immunology

External Links

Snippet

Antigen‐presenting cell‐associated four‐domain MHC class II (MHC‐II) molecules play a central role in activating autoreactive CD4+ T cells involved in multiple sclerosis (MS) and type 1 diabetes (T1D). In contrast, two‐domain MHC‐II structures with the same covalently …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids

Similar Documents

Publication Publication Date Title
Burnett et al. Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination
Spadaro et al. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein
Zerrahn et al. The MHC reactivity of the T cell repertoire prior to positive and negative selection
US20140170168A1 (en) Antibodies which bind soluble t-cell receptor ligands
Willemze et al. The influence of ACPA status and characteristics on the course of RA
Snir et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA–DRB1* 0401–positive humanized mice and rheumatoid arthritis patients
Ali et al. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies
Tran et al. T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8
Lang et al. New autoantibody mediated disorders of the central nervous system
Mannering et al. The case for an autoimmune aetiology of type 1 diabetes
Nixon et al. Fully human monoclonal antibody inhibitors of the neonatal fc receptor reduce circulating IgG in non-human primates
Wenzlau et al. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects
Wang et al. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis
Landry et al. Proinsulin-reactive CD4 T cells in the islets of type 1 diabetes organ donors
Pendergraft III et al. Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease
Roep et al. Molecular mimicry in type 1 diabetes: immune cross‐reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus
Chow et al. Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121–140 and GAD65 250–266 in T1D development
Li et al. Molecular level characterization of circulating aquaporin-4 antibodies in neuromyelitis optica spectrum disorder
Matsumoto et al. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice
Kirvan et al. IgG2 rules: N-acetyl-β-D-glucosamine-specific IgG2 and Th17/Th1 cooperation may promote the pathogenesis of acute rheumatic heart disease and be a biomarker of the autoimmune sequelae of Streptococcus pyogenes
Loh et al. The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4
Chow et al. Discriminative T cell recognition of cross-reactive islet-antigens is associated with HLA-DQ8 transdimer–mediated autoimmune diabetes
Izaki et al. Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs
Kroenke et al. Immune complex formation is associated with loss of tolerance and an antibody response to both drug and target
Pachlopnik et al. Natural anti-FcεRIα autoantibodies may interfere with diagnostic tests for autoimmune urticaria